IFI27 has been proposed as a possible therapeutic target in HIV infections, since it has been found that expression of IFI27 was upregulated in HIV-positive patients and downregulated in patients receiving antiretroviral therapy (Huang et al., 2022). This evidence concerns the gene IFI27 and HIV infectious disease.